Literature DB >> 3261240

EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.

D F Stern1, M P Kamps.   

Abstract

p185neu is a receptor-like protein encoded by the neu/erbB-2 proto-oncogene. This protein is closely related to the epidermal growth factor (EGF) receptor, but does not bind EGF. We report here that incubation of Rat-1 cells with EGF stimulates tyrosine phosphorylation of p185. This effect is specific to EGF since neither platelet derived growth factor (PDGF) nor insulin, which also bind to receptors with ligand-stimulated tyrosine kinase activity, induced tyrosine phosphorylation of p185. The EGF-stimulated tyrosine phosphorylation of p185 and of the EGF receptor occurred with similar kinetics and EGF dose-responses, and both phosphorylations were prevented by down-regulation of the EGF receptor with EGF. Since p185 does not bind EGF, these results suggested that p185 is a substrate for the EGF receptor kinase. Incubation of cells with EGF before lysis stimulated the tyrosine phosphorylation of p185 in immune complexes. This suggested that EGF, acting through the EGF receptor, can regulate the intrinsic kinase activity of p185.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261240      PMCID: PMC454426          DOI: 10.1002/j.1460-2075.1988.tb02906.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

2.  Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters.

Authors:  A C King; P Cuatrecasas
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

3.  Phosphorylation activates the insulin receptor tyrosine protein kinase.

Authors:  O M Rosen; R Herrera; Y Olowe; L M Petruzzelli; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

4.  C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  C Cochet; G N Gill; J Meisenhelder; J A Cooper; T Hunter
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

5.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

6.  Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells.

Authors:  T Hunter; J A Cooper
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

7.  Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas.

Authors:  L C Padhy; C Shih; D Cowing; R Finkelstein; R A Weinberg
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

8.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

9.  Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells.

Authors:  A R Frackelton; A H Ross; H N Eisen
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

10.  Cyclic AMP treatment of Rous sarcoma virus-transformed Chinese hamster ovary cells increases phosphorylation of pp60src and increases pp60src kinase activity.

Authors:  C W Roth; N D Richert; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

View more
  64 in total

1.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors:  R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Epidermal growth factor receptor: elements of intracellular communication.

Authors:  S M Hernández-Sotomayor; G Carpenter
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

3.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

4.  Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.

Authors:  C L Burke; D F Stern
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

7.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.

Authors:  M Marikovsky; K Breuing; P Y Liu; E Eriksson; S Higashiyama; P Farber; J Abraham; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.

Authors:  Catia Cemeus; Tong T Zhao; Gordon M Barrett; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

9.  Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.

Authors:  W J Muller; C L Arteaga; S K Muthuswamy; P M Siegel; M A Webster; R D Cardiff; K S Meise; F Li; S A Halter; R J Coffey
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

Authors:  E Tzahar; H Waterman; X Chen; G Levkowitz; D Karunagaran; S Lavi; B J Ratzkin; Y Yarden
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.